Current research on radiomics in rectal cancer mainly focuses on predicting aspects such as complete remission after neoadjuvant therapy for advanced rectal cancer, lymph node metastasis, KRAS/NRAS gene mutations, and microsatellite instability (MSI). This evidence concerns the gene NRAS and rectal cancer.